Belvedere Trading LLC Adamis Pharmaceuticals Corp Call Options Transaction History

Belvedere Trading LLC

  • $74.4 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$0.14 - $0.22 $2,282 - $3,586
16,300 New
16,300 $2,000
Q1 2022

Apr 20, 2022
SELL
$0.55 - $0.73 $118,195 - $156,877
-214,900 Closed
0 $0
Q4 2021

Jan 25, 2022
BUY
$0.57 - $1.23 $54,947 - $118,572
96,400 Added 81.35%
214,900 $129,000
Q3 2021

Oct 19, 2021
BUY
$0.92 - $1.18 $109,020 - $139,830
118,500 New
118,500 $146,000

About Adamis Pharmaceuticals Corp

ADMP Quotes by TradingView
  • Ticker ADMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 149,983,008
  • Market Cap $73.5M
  • Description
  • Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...
More about ADMP
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email